Tom Huxford

Title: The Innovative Contributions of Tom Huxford

Introduction

Tom Huxford is a notable inventor based in San Diego, California. He has made significant strides in the field of antibody design, particularly focusing on methods that enhance the binding affinity of antibodies to bioactive lipids. His work is crucial in advancing therapeutic applications in biotechnology.

Latest Patents

Huxford holds a patent for "Antibody design using anti-lipid antibody crystal structures." This patent outlines methods for designing optimized antibodies, including humanized or human antibodies, aimed at targeting bioactive lipids. The methods can be performed in silico and are intended to improve the binding affinity of antibodies to their original target lipids, as well as to modify their binding specificity. The patent also includes antibodies produced by these methods and outlines various applications for their use.

Career Highlights

Huxford is currently associated with Lpath, Inc., a company that specializes in developing innovative therapeutic solutions. His work at Lpath has positioned him as a key player in the biotechnology sector, contributing to advancements in antibody design and therapeutic applications.

Collaborations

Tom Huxford has collaborated with notable colleagues, including Roger A. Sabbadini and Jonathan Michael Wojciak. These collaborations have further enriched his research and development efforts in the field of antibody technology.

Conclusion

Tom Huxford's contributions to antibody design represent a significant advancement in biotechnology. His innovative methods and collaborations continue to influence the development of targeted therapies.